The Prevention, Treatment And Diagnosis Of Eye Disease: ARVO Foundation And Pfizer Ophthalmics Honor Carl B. Camras With Translational Research Award
Main Category: Eye Health / BlindnessArticle Date: 26 Oct 2009 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The ARVO Foundation for Eye Research (AFER) and Pfizer Ophthalmics are pleased to announce a series of awards named in honor of Carl B. Camras, MD. Up to three awards of $10,000 each will be presented annually for a period of 10 years to early career researchers.
The AFER/Pfizer Ophthalmics/Carl Camras Translational Research Awards celebrate the life and achievements of Dr. Camras, who passed away earlier this year. Dr Camras was a glaucoma specialist and research scientist who was most widely recognized for developing prostaglandin analogues for the treatment of elevated IOP in patients with glaucoma. During his distinguished career, he took a personal interest in developing the next generation of eye and vision researchers.
"Like Carl Camras, Pfizer Ophthalmics is dedicated to making a difference in the lives of patients by collaborating with stakeholders to advance the science and care in the field of eye disorders," said Robert Besthof, Global Commercial Leader for Pfizer Ophthalmics.
Award recipients will be selected based on their excellence in research and their fundamental scientific discoveries, concepts and novel technologies that have led to or have the promise of leading to the prevention, treatment and diagnosis of eye disease.
Pfizer Ophthalmics is supporting the awards through a donation to AFER. Up to the three annual awards will be presented for the next 10 years at the ARVO Annual Meeting beginning in May 2010.
"AFER is proud to have the opportunity to honor early career researchers for their achievements through the AFER/Pfizer Ophthalmics Translational Research Awards," added Gary Abrams, MD, Chairman of AFER's Board of Governors. "We are grateful for Pfizer Ophthalmics' support and commitment to life-changing ophthalmic research."
2010 AFER/Pfizer Ophthalmic/Carl Camras Research Awards:
AFER is currently accepting nominations online for the 2010 Awards. The deadline for nominations is February 1, 2010. Recipients will be notified in early April, and the awards will be presented on Sunday, May 2, 2010 at the Keynote Session of the 2010 ARVO Annual Meeting in Fort Lauderdale, Fla. Please visit http://www.arvofoundation.org/pfizercamrasawards.
Source:
Jessie Williams
Association for Research in Vision and Ophthalmology
Visit our eye health / blindness section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/168632.php>
APA
http://www.medicalnewstoday.com/releases/168632.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



